Paul Ruff
South African Medical Research Council(ZA)University of the Witwatersrand(ZA)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Viral-associated cancers and disorders, Genetic factors in colorectal cancer, Global Cancer Incidence and Screening
Most-Cited Works
- → Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer(2009)3,835 cited
- → Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer(2013)2,231 cited
- → Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study(2010)1,795 cited
- → Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen(2012)1,376 cited
- → Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer(2014)599 cited
- → Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study